Back to UBS Group AG UBS Group AG

TELOTELO
Showing 8 of 9 quarters

Position history for UBS Group AGUBS Group AG's holdings in TELOMIR PHARMACEUTICALS INC

UBS Group AG holds 7,959 shares of TELO (TELOMIR PHARMACEUTICALS INC), worth $10,187 as of 2026-Q2. The position was decreased (-13.6% shares).

Current Value

$10,187

Current Shares

7,959

Total Value Change

-$14,235

Total Shares Change

+4,155

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
7,959
-13.6%
$10,1870.0%$1.28
0
2026-Q1
Decreased
9,213
-34.4%
$11,9770.0%$1.30
0
2025-Q4
Decreased
14,048
-77.9%
$18,6840.0%$1.34
0
2025-Q3
Increased
63,536
+30.4%
$88,3140.0%$1.34
19
2025-Q2
Increased
48,731
+216.1%
$60,9140.0%$1.53
23
2025-Q1
Decreased
15,416
-38.1%
$49,7940.0%$3.95
0
2024-Q4
Increased
24,926
+555.3%
$102,6950.0%$4.64
24
2024-Q3
Decreased
3,804
-35.9%
$24,4220.0%$6.82
0

Other major holders of TELO: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used